CCL2 and breast cancer: Estrogen exposure facilitated the proliferation, invasion, and metastasis of hormone-dependent BC cells and promoted angiogenesis via the increased secretion of CCL2 in vitro and in vivo, which could be inhibited by the CCR2 antagonist RS102895.